Dose selection in seamless phase II/III clinical trials based on efficacy and safety

Peter K. Kimani, Nigel Stallard, Jane L. Hutton

Research output: Contribution to journalArticlepeer-review

27 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Dose selection in seamless phase II/III clinical trials based on efficacy and safety'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science